Balt, Inc., developer of the investigational Squid liquid embolic, recently announced the publication of STEM—the Squid t ...

Route 92 Medical, Inc. recently announced that its line of neurovascular intervention products has received CE Mark approval un ...

Viz.ai announced new clinical data showing positive outcomes with real-world impact of the company’s technology in clinic ...

Terumo Interventional Systems, a division of Terumo Corporation, announced the expansion of the company’s radial-to-perip ...

Inari Medical, Inc. announced that it has received national reimbursement approval from the Japanese Ministry of Health, ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, ann ...

Fluidx Medical Technology, Inc. announced that the first patient has been treated in the prospective, multinational, clinical ...

IceCure Medical Ltd. recently announced the FDA Medical Device Advisory Committee Panel’s favorable recommendation (voti ...

Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...

Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Intera Oncology Inc. Boston ...

Bentley InnoMed GmbH announced the first-in-human implantation of the BeFlared stent graft system, which recently received CE ...

Merit Medical Systems, Inc. announced 6-month findings from the single-arm arteriovenous graft (AVG) cohort of the WAVE pivota ...